These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8306442)
21. Simultaneous determination of leukotrienes B4 and E4 in whole blood and of leukotriene E4 in urine of rabbit by reversed-phase high-performance liquid chromatography. Celardo A; Dell'Elba G; Eltantawy ZM; Evangelista V; Cerletti C J Chromatogr B Biomed Appl; 1994 Aug; 658(2):261-9. PubMed ID: 7820254 [TBL] [Abstract][Full Text] [Related]
22. Efficient method for the quantitation of urinary leukotriene E4: extraction using an Empore C18 disk cartridge. Mita H; Oosaki R; Mizushima Y; Kobayashi M; Akiyama K J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):461-6. PubMed ID: 9188837 [TBL] [Abstract][Full Text] [Related]
23. Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis. Fauler J; Thon A; Tsikas D; von der Hardt H; Frölich JC Arthritis Rheum; 1994 Jan; 37(1):93-7. PubMed ID: 8129769 [TBL] [Abstract][Full Text] [Related]
25. Cysteinyl leukotrienes in the bile of patients with obstructive jaundice. Uemura M; Kojima H; Buchholz U; Kikuchi E; Matsumoto M; Kikukawa M; Imazu H; Fukui H; Tsujii T; Keppler D J Gastroenterol; 2002; 37(10):821-30. PubMed ID: 12424566 [TBL] [Abstract][Full Text] [Related]
26. Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxication. Uemura M; Lehmann WD; Schneider W; Seitz HK; Benner A; Keppler-Hafkemeyer A; Hafkemeyer P; Kojima H; Fujimoto M; Tsujii T; Fukui H; Keppler D Gastroenterology; 2000 Jun; 118(6):1140-8. PubMed ID: 10833489 [TBL] [Abstract][Full Text] [Related]
27. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442 [TBL] [Abstract][Full Text] [Related]
28. Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4. Hagmann W; Denzlinger C; Rapp S; Weckbecker G; Keppler D Prostaglandins; 1986 Feb; 31(2):239-51. PubMed ID: 3515428 [TBL] [Abstract][Full Text] [Related]
29. Gas chromatographic-mass spectrometric determination of leukotriene E4 in human urine using deuterium-labelled leukotriene E4 standards. Tsikas D; Fauler J; Gutzki FM; Röder T; Bestmann HJ; Frölich JC J Chromatogr; 1993 Dec; 622(1):1-7. PubMed ID: 8120106 [TBL] [Abstract][Full Text] [Related]
30. An improved assay for urinary LTE4. Sala A; Armetti L; Piva A; Folco G Prostaglandins; 1994 Apr; 47(4):281-92. PubMed ID: 8041871 [TBL] [Abstract][Full Text] [Related]
31. Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis. Higashi N; Taniguchi M; Mita H; Ishii T; Akiyama K Allergy; 2003 Jun; 58(6):476-80. PubMed ID: 12757446 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of cysteinyl leukotrienes by the isolated perfused rat kidney. Fauler J; Wiemeyer A; Yoshizawa M; Schurek HJ; Frolich JC Prostaglandins; 1991 Sep; 42(3):239-49. PubMed ID: 1664114 [TBL] [Abstract][Full Text] [Related]
33. Urinary leukotriene E4 excretion in exercise-induced asthma. Taylor IK; Wellings R; Taylor GW; Fuller RW J Appl Physiol (1985); 1992 Aug; 73(2):743-8. PubMed ID: 1328140 [TBL] [Abstract][Full Text] [Related]
34. Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine. Hagmann W; Parthé S; Kaiser I Biochem J; 1989 Jul; 261(2):611-6. PubMed ID: 2549977 [TBL] [Abstract][Full Text] [Related]
35. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis. Lueke AJ; Meeusen JW; Donato LJ; Gray AV; Butterfield JH; Saenger AK Clin Biochem; 2016 Sep; 49(13-14):979-82. PubMed ID: 26908217 [TBL] [Abstract][Full Text] [Related]
36. Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects. Maclouf J; Antoine C; De Caterina R; Sicari R; Murphy RC; Patrignani P; Loizzo S; Patrono C Am J Physiol; 1992 Jul; 263(1 Pt 2):H244-9. PubMed ID: 1322060 [TBL] [Abstract][Full Text] [Related]
37. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat. Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116 [TBL] [Abstract][Full Text] [Related]
38. The challenge procedure influences the extent of allergen-induced urinary excretion of leukotriene E4. Kumlin M; Dahlén B Clin Exp Allergy; 2000 Apr; 30(4):585-9. PubMed ID: 10718858 [TBL] [Abstract][Full Text] [Related]
39. Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Carry M; Korley V; Willerson JT; Weigelt L; Ford-Hutchinson AW; Tagari P Circulation; 1992 Jan; 85(1):230-6. PubMed ID: 1309444 [TBL] [Abstract][Full Text] [Related]
40. Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performance. Allen SP; Chester AH; Dashwood MR; Tadjkarimi S; Piper PJ; Yacoub MH Circulation; 1994 Jul; 90(1):515-24. PubMed ID: 8026041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]